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2Abstract
The accumulation of mildly deleterious missense mutations in individual human genomes has 
been proposed to be a genetic basis for complex diseases. The plausibility of this hypothesis 
depends on quantitative estimates of the prevalence of mildly deleterious de novo mutations and 
polymorphic variants in humans and on the intensity of selective pressure against them. We 
combined analysis of mutations causing human Mendelian diseases, human-chimpanzee 
divergence and systematic data on human SNPs and found that about 20% of new missense 
mutations in humans result in a loss of function, while about 27% are effectively neutral. Thus, 
more than half of new missense mutations have mildly deleterious effects. These mutations give 
rise to many low frequency deleterious allelic variants in the human population as evident from a 
new dataset of 37 genes sequenced in over 1,500 individual human chromosomes. Surprisingly, 
up to 70% of low frequency missense alleles are mildly deleterious and associated with a 
heterozygous fitness loss in the range 0.001-0.003. Thus, the low allele frequency of an amino 
acid variant can by itself serve as a predictor of its functional significance. Several recent studies 
have reported a significant excess of rare missense variants in disease populations compared to 
controls in candidate genes or pathways. These studies would be unlikely to work if most rare 
variants were neutral or if rare variants were not a significant contributor to the genetic 
component of phenotypic inheritance. Our results provide a justification for these types of 
candidate gene (pathway) association studies and imply that mutation-selection balance may be a 
feasible mechanism for evolution of some common diseases.
3Introduction
Many common human diseases have a strong heritable component. While modern human 
genetics has been incredibly successful in determining the genetic causes of rare Mendelian 
diseases, complex diseases have proven to be a more challenging problem1,2. Genetic variation 
that influences an individual's susceptibility to most such diseases is still largely unidentified. Of 
special interest are missense mutations, as many of them are believed to have non-marginal 
functional effects1. The effects of a missense mutation on molecular function, phenotype and 
organism fitness can be extremely diverse. A missense mutation can be lethal or cause severe 
Mendelian disease; alternatively, it can be mildly deleterious, effectively neutral or beneficial. 
Knowledge of relative frequencies of these types of mutations and their contributions to 
population genetic variation is important for understanding the evolutionary background of 
common disease and can inform design of human genetic studies.
The effect of a missense mutation on organism is always multifaceted and can be considered 
from multiple perspectives - biochemical, medical or evolutionary. The relationship between the 
effects of amino acid substitution on protein activity, human health and an individual's 
evolutionary fitness is not trivial. A mutation that damages protein structure does not necessarily 
lead to a detectable human disease phenotype, and a mutation that predisposes an individual 
towards a disease is not necessarily evolutionary deleterious. Fixation of completely deactivating 
mutations (pseudogenezation) was apparently a common event during recent human evolution3, 
indicating that a mutation abolishing protein activity is not necessarily subject to purifying 
selection. Substitutions leading to abnormal hemoglobin function that cause sickle cell anemia 
4are apparently negative from both biochemical and medical points of view. Nevertheless, they 
can not be considered negative from an evolutionary point of view since balancing selection has 
brought them to high frequency in many parts of the world. To clearly distinguish different 
aspects of negative mutations we will use the term damaging to refer to a mutation that decreases 
protein activity, the term detrimental to refer to a mutation that predisposes an individual 
towards a disease, and the term deleterious to refer to a mutation that has been subject to 
purifying selection.
A high incidence rate for many complex diseases suggests that a surprisingly high cumulative 
frequency of medically detrimental variants should be present in the human population. It 
remains uncertain why such polymorphism may persist without being eliminated by purifying 
selection. Currently, two major lines of reasoning exist that explain this apparent paradox. The 
first considers various complex evolutionary scenarios and treats positive or balancing selection 
as a major force that can drive medically detrimental mutations to high frequencies. The second 
line of reasoning postulates a high mutation rate as a major factor that determines the cumulative 
frequency of detrimental polymorphism in population.
The first hypothesis states that the majority of polymorphism predisposing an individual to a 
complex disease, though medically detrimental at the present time, were not evolutionarily 
deleterious. There are a number of possible phenomena that might help a polymorphic variant 
which confers a susceptibility to a disease phenotype escape purifying selection. One of them is a 
late disease onset, when detrimental phenotypic consequences of a mutation strike after the 
reproductive age, and thus, do not affect the individual's number of offspring. A number of 
5earlier studies show, however, that this phenomenon is unlikely to be common. These studies 
suggest that most of the mutations that affect phenotypes at old age are likely to have a small 
pleiotropic effect earlier in life4,5. Changing direction of selection is another mechanism that can 
explain how presently detrimental mutations could have escaped purifying selection6. Human 
lifestyle, environment and nutrition have changed dramatically and some mutations that were 
neutral or even beneficial in hunter-gatherer societies tens of thousands of years ago might have 
become medically detrimental in modern human society. The best known example of this type of 
reasoning is a “thrifty genes” hypothesis7 that postulates that polymorphisms that predispose 
modern humans to obesity and are presently medically detrimental were able to rise to high 
frequency in population due to associated selective advantages at the times of scarce food 
sources. Yet another mechanism, balancing selection, can also maintain deleterious mutations in 
a population if heterozygous individuals have a strong evolutionary advantage8. A classic 
example for this mechanism is the hemoglobin mutation that is protective against malaria in a 
heterozygote state and simultaneously leads to sickle cell anemia in a homozygous state9. The 
fourth phenomenon that can lead to a high frequency of medically detrimental mutation is 
antagonistic pleiotropy, when the negative effect of mutation on one trait is compensated by its 
positive effect on another10. None of the these evolutionary scenarious, however, have been 
shown to be frequent enough to account for a large number of human common complex diseases. 
The second theory postulates that the majority of medically detrimental polymorphism are also 
mildly evolutionary deleterious and the observed frequency of disease-predisposing genetic 
variation is the result of mutation-selection balance. The key assumption here is that majority of 
disease-causing mutations are both medically detrimental and evolutionary deleterious, but the 
6pressure of purifying selection acting upon them is reasonably weak. A high rate of mildly 
deleterious mutations associated with disease risk counterbalances the action of purifying 
selection.
Mutation selection balance was, initially, theoretically treated by Kimura11. It was, then, both 
advocated12 and argued against13 as a mechanism capable of maintaining high level of genetic 
variance in natural populations. In the last decade, partially due to popularity of common disease/ 
common variant (CD/CV) hypothesis, mutation selection balance was frequently overlooked as a 
mechanism that can explain existence of many common, harmful, heritable disorders. Recently, 
however, mutation selection balance has been put forward, again, as a plausible mechanism of 
the maintenance of the deleterious genetic variation14,15,16.
Obviously, mutation-selection balance can only become a feasible evolutionary explanation for 
common disease if a sufficient fraction of de novo mutations in humans are mildly deleterious. 
The estimation of the fraction of mildly deleterious missense mutations and corresponding 
fraction among low frequency human polymorphism is the subject of this work.
The evolutionary origin of present-day detrimental polymorphism has an important implication 
for the spectrum of disease-predisposing alleles. If the majority of medically detrimental 
mutations were not evolutionarily deleterious, they might have risen to a high frequency in the 
population, and thus the common disease/common variant hypothesis is viable. On the contrary, 
if the majority of medically detrimental polymorphism are mildly deleterious and their 
cumulative high frequency in the population is being maintained by mutation/selection balance, 
7then the common disease/rare variant alternative is likely to hold true. Given the high incidence 
rate of many complex diseases, the mutation/selection balance hypothesis can be feasible only if 
a large fraction of de novo mutations is associated with moderate selection coefficients, so that, 
despite being deleterious, they can still achieve detectable frequencies in the human population.
Earlier theoretical studies in the framework of a mutation-selection model of common disease 
focused on the frequency spectrum of susceptibility alleles. Pritchard17 and Pritchard & Cox18 
argued that low frequency alleles are major contributors to common disease, whereas Reich & 
Lander19 advocated the common disease-common variant hypothesis. Pritchard17 suggested that 
the rate of susceptibility mutations is high and that they are under pressure of weak purifying 
selection, leading to an abundance of rare variants. Reich & Lander19 did not focus on the 
question of how an individual deleterious variant could reach high population frequency. Given 
the high frequency of the phenotype, they considered allelic identity in the disease class, which 
depended on the rate of mutations conferring disease susceptibility. Thus, both models depend 
on the rate of deleterious mutations involved in disease and on strength of selection against new 
mutations. Both studies used estimates of mutation rate based on examples from a few loci and 
mutations causing fully penetrant Mendelian phenotypes; mutations involved in complex 
disease, on the other hand, may have smaller effects. The difference in conclusions is mostly 
explained by the difference in numerical values of the rate of deleterious mutations and strength 
of selection acting on them. It should be stressed that the deleterious mutation rate depends not 
only on the raw per nucleotide substitution rate but also on fraction of de novo mutations that are 
deleterious. Reliable estimation of these parameters requires integration of several types of data.
8We combined in our analysis data on human Mendelian disease-causing mutations, human-
chimpanzee divergence and genetic variation in the modern human population. The availability 
of new data on human polymorphism detected in 37 obesity related genes sequenced in 756 
individuals allowed us to investigate the important class of mildly deleterious mutations. 
Purifying selection acting on this type of mutation is strong enough to effectively prohibit their 
fixation, but they are present in the population at low frequencies and can be detected if a large 
number of individuals is sequenced.
We estimated that more than 50% of de novo missense mutations and 70% of missense SNPs 
detected only once among 1,500 chromosomes are mildly deleterious. Such mildly deleterious 
amino acid substitutions are associated with selection coefficients within a surprisingly narrow 
range of 0.001-0.003.
A high fraction of mildly deleterious mutations among missense mutations suggests that 
mutation-selection balance can be a possible explanation for the existence of common disease 
with complex inheritance. The observation that the majority of human rare non-synonymous 
variants are deleterious and thus, of significance to function and phenotype, strongly supports a 
resequencing strategy for candidate gene association studies: a disease population is expected to 
have a higher rate of rare amino acid variants than healthy controls in genes involved in disease. 
9Data and Methods
Mutations associated with Mendelian diseases
For information on strongly detrimental mutations we used Human Gene Mutation Database 
(HGMD)20 that contains over 50,000 disease-causing mutations of various types, including 
missense, nonsense and splice-sites mutations. Disease-associated polymorphism comprise only 
very small fraction of HGMD and the majority of mutations included in the database are fully 
penetrant and cause simple Mendelian diseases20. HGMD lacks information on how many times 
each individual mutation has been identified. However, assuming that mutations follow the 
Poisson statistics, presence of mutations detected multiple times would not significantly affect 
our estimates unless majority of all possible nonsense mutations were detected, which is highly 
unlikely for most of genes.
HGMD may include genes with complete loss of function mutations being embryonically lethal. 
It contains some gain of function mutations and mutations with incomplete penetrance. 
Although fraction of these mutations in HGMD is probably small, their presence can cause bias 
of our estimates. Thus, we repeated our analysis on a smaller but well characterized set of 
autosomal dominant or X-linked disease genes originally collected by Kondrashov from locus 
specific databases for estimating mutation rate in humans21. We extracted information on 
missense and nonsense mutations in these genes from individual HGMD entries. To ensure that 
complete loss of function is not lethal we restricted our analysis to 26 genes that had at least 5 
reported nonsense mutations. All missense mutations in these genes are believed to be loss-of-
function mutations.
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Human polymorphism data – new large resequencing dataset
For our analysis of very low frequency nonsynonymous SNPs we used a new large resequencing 
dataset described in the accompanying manuscript by Ahituv et al. Complete exonic sequences 
and their splice sites were sequenced in 58 genes with potential involvement in obesity in 379 
obese and 378 lean individuals. Complete sequencing of more that 1,500 chromosomes provided 
us with an opportunity to study nonsynonymous SNPs at very low frequencies. All individuals 
included in the study are of Caucasian ancestry.
Since this dataset is not based on a random population sample and is phenotipically biased, we 
limited our analysis to 37 autosomal genes for which no evidence of their effect on obesity was 
detected. In these genes there was no statistically significant excess of variation in either obese or 
lean group. 71 and 79 missense variants were found within lean and obese cohorts respectively. 
Random resampling subsets matching the SeattleSNP dataset in size produced estimates highly 
similar to obtained from smaller systematic datasets, that further supported absence of bias in 
chosen 37 genes subset.
Human polymorphism data – publicly available data
In addition to our new resequencing dataset we used three publicly available datasets that contain 
sufficient information on rare nonsynonymous alleles: 1) dataset generated by Environmental 
Genome Project (NIEHS-EGP)22 in which over 500 genes involved in DNA repair and cell cycle 
pathways were sequenced in at least 90 unrelated individuals; 2) dataset generated by 
SeattleSNPs project (SeattleSNPs) in which over 200 genes involved in the inflammatory 
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responses were sequenced in at least 46 individuals; and 3) dataset generated by Japanese Single 
Nucleotide Polymorphisms (JSNP)23 project in which polymorphic sites in over 8,000 genes 
were discovered using panel of 12 individuals and later genotyped in 750 individuals.
Mutations fixed in the human lineage after divergence from chimpanzee
To obtain information on mutations fixed in the human lineage after divergence from 
chimpanzee we used human/chimpanzee and human/macaque whole genome pairwise 
alignments constructed with blastz program. These alignments were obtained from UCSC ftp 
site. We compared all nucleotide substitutions detected between human and chimp whole 
genome assemblies to dbSNP database24 that contain information on most of known human 
genetic variation. Substitutions that were detected as present day polymorphisms were excluded 
from our analysis of human/chimpanzee divergence. Macaque sequence was used as an outgroup 
to distinguish mutations fixed in the human lineage versus mutations fixed in the chimpanzee 
lineage. Accordingly, we ignored sites at which macaque nucleotide was different from both 
human and chimpanzee nucleotides. Due to this procedure, we potentially excluded a small 
fraction of very rapidly evolving sites, thus slightly underestimating the fraction of “effectively 
neutral” amino acid substitutions.
Context-dependent mutation model
Accurate estimation of selective constraints in protein coding regions requires a context-
dependent mutational model25. We constructed a context-dependent mutation rate matrix that 
described the probability of de novo mutation occurrence, before any selection has taken place. 
With such a mutability model we were able to compare the observed number of various 
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substitutions with the corresponding number expected under neutrality and, from such 
comparison, to draw a conclusion on the strength of purifying selection.
We restricted our analysis to single nucleotide substitutions, excluding other less common types 
of mutations. The real mutational spectrum is quite complex – CpG dinucleotides have mutation 
rate an order of magnitude higher than other dinucleotides, transitions are notably more frequent 
than transversions and some other, more subtle, context-dependent effects were reported to 
exist26. Various mutation models of different degrees of sophistication have been previously 
used27. The availability of human, chimpanzee and (incomplete) baboon genomic sequences 
allowed us to calculate an empirical “directed” 64x3 mutation matrix for triplets (with 
probabilities for all XY1Z to XY2Z single nucleotide substitutions). Such mutational model that 
takes into account nucleotide, its closest neighbors and direction of substitution should capture 
most of the known fine-scale mutation rate context dependencies. We used a second-order model 
of dependence on neighboring positions in order to capture all context-dependent effects on 
mutation rate. We also introduced statistical correction for back substitutions in the baboon 
lineage.
We made alignments of human, chimpanzee and baboon sequence taken from ENCODE 
regions28 using the multiple sequence aligner TBA29. The frequencies of all nucleotide triples in 
the aligned sequences were counted (ignoring any triples containing gaps). Directionality of 
mutation (whether a substitution has occurred in human or in chimpanzee lineage) was 
determined using baboon sequence.
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Calculated matrix was in good agreement with other recently published context-dependent 
models of neutral evolution30-32. For example, r2 correlation coefficient between our matrix and 
matrix from Siepel and Haussler30 is 96%)
Gene sets
Population and evolutionary dynamics of genes located on sex chromosomes differ from the rest 
of genome. To avoid unnecessary complications in our analysis we used only autosomal genes.
To calculate nonsynonymous to synonymous mutations ratio characteristic for the entire human 
genome we used 14095 reliably annotated autosomal genes from “Consensus CDS” project.
Confidence of the estimates
Analysis of human-chimpanzee divergence is based on the complete proteome and the analysis 
of the HGMD database incorporates the most comprehensive set of disease genes. However, 
human SNP data are represented by much smaller gene sets. Therefore, it is necessary to assign 
confidence to statistical estimates obtained from these sets. Even though these datasets have 
large numbers of SNPs, these mutations were found in different genes possessing different 
properties. Thus, sampling error of the estimates is expected to be mostly determined by 
sampling of genes rather than individual mutations.
We computed standard errors from standard deviation of estimates obtained from random non-
overlapping subsets of the data. Although standard errors are mostly used for estimates of mean, 
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we tested in a series of simulations that standard errors computed using non-overlapping subsets 
satisfactory approximate the error of the estimates presented in this work.
Results
Strongly detrimental mutations
As a first step in our analysis of spectrum of potential effects of amino acid mutations we 
estimated the fraction of de novo missenses that are strongly detrimental. We define a missense 
mutation as strongly detrimental if it causes complete protein function loss often seen in 
Mendelian diseases.
Nonsense mutations that introduce premature stop codons can serve as a standard of “strong 
detrimentality”. 26,305 missense and 6,764 nonsense mutations are listed in The Human Gene 
Mutation Database. Although HGMD has an inherent ascertainment bias, following21,33, we 
believe that mutations causing the same phenotype are equally likely to be deposited in the 
database, regardless of their type – nonsense, missense or splice-site. If all missense mutations 
were as likely to result in complete loss of function, and subsequently, in strong disease 
phenotype as nonsense mutations, then the ratio of missense to nonsense mutations in HGMD 
database would be similar to the expected theoretical ratio for de novo mutations. In reality, it is 
significantly lower. Using our mutation rate model described above we estimated that 
approximately 19.7 missense substitutions occur per each nonsense substitution genome-wide 
(14,095 human genes from “Consensus CDS” project were used for calculation of genome-wide 
values). At the same time, only 3.9 missenses were observed per each nonsense substitution 
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among disease-causing mutations in HGMD database (Figure 1A). Such a difference indicates 
that a large fraction of missense mutations is not deleterious enough to be visible through such a 
“strong phenotype filter” as detection and inclusion in HGMD. Using the obtained numbers we 
can estimate that only 20% (3.9/19.7) of missense mutations are strongly detrimental.
Mutations that disrupt dinucleotides of the core splicing sites consensus (GT/AG) often lead to 
an almost complete loss of gene function. These splice site substitutions can be used as 
“reference” strongly detrimental mutations the same way as we used nonsense mutations. We 
calculated that genome-wide approximately 36.5 de novo missense mutations are expected to 
occur per each de novo splice site mutation. However, in HGMD only 7.6 missense mutations 
are listed per each mutation in the splice site (Figure 1B). Accordingly, we can estimate that the 
fraction of strongly deleterious mutations among missenses is approximately 21%. This number 
is in remarkable correspondence with the value obtained using nonsense mutations as a 
reference.
Although HGMD provides a comprehensive set of disease mutations, it is very heterogeneous 
and includes mutations of incomplete penetrance, gain of function mutations and possibly 
mutations in genes with embryonically lethal complete loss of function. Presence of mutations in 
two latter categories would bias our estimate upward, i.e. would lead to a conservative estimate 
for the purpose of this work. However, to test whether the upward bias can be significant, we 
analyzed a much smaller set of very well characterized genes involved in autosomal dominant or 
X-linked simple Mendelian diseases. All mutations in this set are believed to lead to loss of 
function and complete function loss is not lethal. After taking into account individual genes 
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lengths, 21% of new missense mutations in the set were estimated to be strongly detrimental. 
Effectively neutral mutations
As the second step in our analysis of spectrum of potential effects of amino acid substitutions we 
estimated a fraction of de novo missense mutations that are effectively neutral. We define a 
missense mutation as effectively neutral if its probability to be fixed in the ancestral human 
population after divergence from chimpanzee would have been similar to that of synonymous 
substitutions. While synonymous substitutions were shown not to be completely selectively 
neutral34,35,36 (reviewed in Chamary et al.37), the effect on fitness of the vast majority of them in 
the human population is believed to be relatively small.
We estimated (see Figure 1C) that 2.23 de novo missense mutations occur per each synonymous 
mutation. However, among substitutions fixed in the human lineage after divergence from 
chimpanzee (calculated with the use of macaque genomic sequence as an outgroup) only 0.60 
missense mutations were present per a single synonymous substitution. The rest of missense 
mutations were apparently eliminated by purifying selection. From these values, we can estimate 
that approximately 27% (0.6/2.23) of missense mutations in human proteins are similar in effect 
to synonymous substitutions.
This estimate is sensitive to advantageous mutations driven to fixation by positive selection and 
to very slightly deleterious mutations fixed by drift. Presence of these mutations would bias our 
estimate of fraction of mildly deleterious mutations downward, i.e. our estimate is conservative 
for our purpose. It is also conservative with respect to purifying selection at synonymous sites. 
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Thus, this estimate can be viewed as an estimate of fraction of new missense mutations which 
are not associated with fitness loss larger than the reciprocal of effective population size.
Mildly deleterious polymorphisms
We analyzed two extremes of the potential effects of amino acid changes on fitness and 
estimated that, among de novo missense mutations in human proteins, approximately 20% are 
strongly detrimental while another 27% are effectively neutral. Simple arithmetic provides us 
with the conclusion that the majority – 53% - of all de novo missense mutations are, in fact, 
mildly deleterious. Mildly deleterious mutations can reach low, but detectable population 
frequencies. We next posed a question – if fraction of mildly deleterious mutations among de 
novo mutations is 53%, what is the fraction of mildly deleterious alleles among rare and common 
nonsynonymous SNPs in the human population?
First, we considered very rare missense polymorphisms. We analyzed only polymorphic sites at 
which at least 1400 chromosomes out of 1514 have been successfully sequenced. Over 60% of 
nonsynonymous SNPs discovered in our set of 37 autosomal genes sequenced in 757 individuals 
were detected as singletons (i.e. were found in heterozygote state in a single individual).  Even 
though singletons represent very low frequency SNPs, probability that they are de novo 
mutations is diminishingly small.  The number of nsSNPs detected at higher frequencies was 
significantly smaller and, thus, singletons represented the only group of rare missense alleles that 
had enough data for a statistically significant analysis.
We estimated the relative fraction of de novo missense mutations represented by singletons. This 
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estimate was based on a comparison of the observed number of nonsynonymous substitutions per 
one synonymous mutation (Na/Ns ratio) with the corresponding theoretical number expected 
under neutral evolution (Na0/Ns0 ratio). It should be noted that the assumption that natural 
selection is absent (neutral evolution) is equivalent to the assumption that natural selection has 
not yet acted (de novo mutations).
As presented in Figure 2 and Table 1, the Na0/Ns0 ratio calculated using our neutral model of 
evolution for 37 genes of large resequencing dataset was equal 2.204. Experimental Na/Ns ratio 
for singletons calculated for the same dataset was equal 1.49. Given these values we determined 
that only 32% (1-1.49/2.20) of missense mutations are deleterious to the extent that they have 
very low probability to be found even once in the sample of 1500 chromosomes. Standard error 
of this estimate is 2%.
The experimental Na/Ns ratio for amino acid substitutions fixed in the set of 37 genes in the 
human lineage after divergence from chimpanzee is equal 0.44 This means that approximately 
20% of all missense mutations in these genes are effectively neutral – a value close to the 
genome-wide average.
Human genetic variation detected in the set of 37 genes sequenced in 756 individuals provided 
an opportunity to get an insight into human genetic variation of very low allele frequency. 
However, it lacks a significant quantity of data on common genetic variation. To fill this gap we 
used three publicly available datasets: 1) dataset generated by Environmental Genome Project 
(NIEHS-EGP) in which over 500 genes involved in DNA repair and cell cycle pathways were 
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sequenced in at least 90 unrelated individuals; 2) dataset generated by SeattleSNPs project 
(SeattleSNPs) in which over 200 genes involved in the inflammatory responses were sequenced 
in at least 46 individuals; and 3) dataset generated by Japanese Single Nucleotide 
Polymorphisms (JSNP) project in which polymorphic sites in over 8,000 genes were discovered 
using panel of 12 individuals and later genotyped in 750 individuals. These datasets also 
contained information on rare genetic variation that we used, although a large fraction of rare 
nsSNPs with frequency below 1% might have been missed in the EGP and SeattleSNP datasets 
because less than 200 chromosomes were sequenced, and in JSNP, because only 12 individuals 
were used for SNP discovery.
Again, using our neutral model of evolution, we calculated predicted Na0/Ns0 ratios, separately for 
EGP, SeattleSNPs and JSNP datasets. Then we calculated experimental Na/Ns ratios for three 
types of substitutions. The first type is rare substitutions that a) were observed only once among 
all chromosomes sequenced (in EGP and SeattleSNPs) or b) had an observed frequency below 
1%(JSNP). The second type is very common polymorphisms, with a frequency of the least 
common allele above 25%. The third type is substitutions fixed in the human lineage after 
divergence with chimpanzee.
We observed that Na/Ns ratios for very common polymorphisms were only very slightly higher 
than Na/Ns ratios for fixed substitutions (Figure 2, Table 1). This fact indicates that the fraction of 
deleterious substitutions among common SNPs is very low. It also supports the notion that the 
fraction of positively selected amino acid substitutions among all mutations in human proteins 
was low38.
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In sharp contrast with common SNPs, Na/Ns ratio for very rare alleles significantly exceeds Na/Ns 
ratios for fixed substitutions (that are presumably neutral). This fact indicates that a very large 
fraction of such rare substitutions are deleterious. The fraction of deleterious mutations among 
observed rare substitutions can be estimated as (Narare/Nsrare)/(Nafixed/Nsfixed). Simple calculations 
reveal that the majority (52%-71%, Table 2) of amino acid substitutions with the observed 
frequency below 1% are mildly deleterious in all datasets. This surprising finding indicates that a 
low frequency of missense mutation per se can serve as a strong predictor of deleterious effect of 
polymorphic variants.
Characteristic selection coefficients of mildly deleterious mutations - theory
We concluded that more than half of newly arising missense mutations are mildly deleterious. 
Such mutations are not present among common polymorphisms but are very common among 
substitutions detected only once in a hundred or more chromosomes. Based on these 
observations we estimated selection coefficients associated with such mutations.
First, we calculated theoretical expected number of mutations with selection coefficient s 
observed only once in a set of m randomly sampled chromosomes. Then, we divided it by the 
corresponding number of neutral mutations to obtain the ratio R1/m(s):
R1 /ms=
[∫
0
1
e−2Ne s 1−x −1
x 1−xe−2Ne s−1
C 1
mx 1−x m−1Cm−1
m xm−11−x dx ]
[∫
0
1
1
x
C 1
mx 1−x m−1Cm−1
m xm−11−xdx ]
 {Equation 1a}
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where Cnk is the binomial coefficient – the number of combinations of size k from a set with n 
elements C k
n= n!
k !n−k !
{Equation 1b}
In the {Equation 1a} Ne represents an effective population size and x the frequency of an 
individual allele in the population. The number of detected mutations was obtained by 
multiplying the theoretical number of all alleles present in population with frequency x by the 
probability of a single allele with frequency x being detected as a singleton in a set of m 
chromosomes, and then by integrating over allele frequency x from 0 to 1. It should be noted that 
an allele is detected as a singleton in a set of m chromosomes if either 1 or m-1 copies are 
present.
Similarly we calculated the theoretical ratio RMAF>0.25(s) for mutations that have been detected as 
polymorphisms in a set of m chromosomes with minor allele frequency (MAF) higher than 25%.
RMAF0.25s =
[∫
0
1
[ e
−2Ne s 1−x −1
x 1−xe−2Ne s−1
∑
0.25m j0.75m
C j
m x j 1−x m− j ]dx ]
[∫
0
1
[ 1
x
∑
0.25m j0.75m
C j
mx j 1−x m− j ]dx ]
 {Equation 2}
These formulas result from an application of diffusion theory to the dynamics of polymorphism 
in populations39. Their two major underlying assumptions are constant effective population size 
and each novel mutation occurring at a new, previously monomorphic site (infinite number of 
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sites model). The dominance coefficient was assumed to be equal 0.5, so if s is the selection 
coefficient associated with a heterozygote, 2s is the selection coefficient associated with a 
homozygote. The exact values of the dominance coefficient are not very important, as long as 
they are high enough to allow selection to operate primarily on heterozygotes.
The dependence of RMAF>0.25(s) and R1/m(s) (for various values of m) on selection coefficient s is 
shown in Figure 3A. We determined that roughly equal fractions of missense mutations can be 
observed as fixed substitutions and as common polymorphisms with minor allele frequency 
above 25% (Fig 2). This observation implies that mildly deleterious mutations are virtually 
absent among frequent SNPs and thus should have selection coefficient values at which 
RMAF>0.25(s) is very close to zero. On the other hand, the majority of mildly deleterious mutations 
have high relative chance to be detected as singletons. For each three resequencing datasets 
(obesity-related, EGP and SeattleSNP) we estimated fraction of de novo mildly deleterious 
missense mutations observed as singletons relative to neutral expectations:
Robserved=
Na/N s
singletons
Na
0 /Ns
0
−
Na /Ns
hum.lin.subst.
Na
0/N s
0
1−F stronglydel.−
Na/Ns
hum.lin.subst.
Na
0/Ns
0  {Equation 3}
Here the numerator reflects the observed fraction of mutations in the mildly deleterious class 
detectable as singletons, which is equal to fraction of all mutations detectable as singletons 
minus fraction of effectively neutral de novo mutations. Denumerator reflects the total fraction of 
mutations arising in the mildly deleterious class. It is given by substracting fraction of strongly 
deleterious de novo mutations (given by Fstrongly del) and neutral mutations from 1.
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Using theoretical dependence of R on selection coefficient (Fig. 3A) for corresponding number 
of sequenced chromosomes m we estimated characteristic selection coefficients for mildly 
deleterious de novo missense mutation for genes in each set. All three estimates fall into a 
relatively narrow range of selection coefficients 0.002-0.02.
Characteristic selection coefficients of mildly deleterious mutations – computer simulations
The major drawback of the above straightforward theoretical approach is the assumption that the 
effective size of the human population is constant and equals 10,000. This assumption was 
shown to be appropriate for common SNPs, most of which are ancient in origin. However, an 
order of magnitude larger effective population size might be more appropriate to describe the 
dynamics of rare polymorphisms. Larger effective population size leads to more efficient 
purifying selection and, as can be seen from {Equation 1a}, lower values of R1/m(s). By 
underestimating Ne we are overestimating R1/m(s), and in reality the R1/m(s) dependence-curve on 
s is shifted to the area of lower values of selection coefficients (Figure 3A).
To analyze the dependence of R1/m(s) and RMAF>0.25(s) under a more realistic human population 
history scenario we simulated evolution under the Wright-Fisher model (assuming constant 
mutation rate and infinite number of unlinked sites). Our model of human population history was 
comprised of the four principal epochs: 1) 100,000 generations of stable effective population size 
15,000; 2) exponential reduction in 100 generations to the size of 7,000; 3) 500 generations of 
stable population size 7,000; 4) exponential growth in 3,000 generations to the effective 
population size 90,000. Such a scenario, where a long period of stable effective population size is 
followed by bottleneck and then by rapid expansion captures key features of human population 
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history. Exact values for the duration of each epoch and corresponding effective population sizes 
were chosen in general agreement with recent literature40-42 and than slightly optimized to better 
describe alleles frequency distributions for non-coding SNPs detected by the Environmental 
Genome Project.
Usage of R1/m(s) and RMAF>0.25(s) dependencies obtained using direct simulation resulted in 
estimate that approximately 0.001–0.003 range of selection coefficients corresponds to mildly 
deleterious class of de novo missense mutations.
Cumulative equilibrium frequency of mildly deleterious polymorphisms in the human genome
We determined that mildly deleterious missense mutations that are not present among common 
polymorphisms are nevertheless numerous among substitutions with a detected population 
frequency below 1% and are associated with selection coefficients in the range of 0.001-0.003 
Using this result, we estimated the equilibrium frequency of such mildly deleterious alleles in the 
human population. Under the assumption of strong selection and large population size (Ns >> 1) 
the cumulative equilibrium frequency of all mildly deleterious gene alleles in the population is:
Freqcumulative=u/s {Equation 4}
where u is mutation rate per gene per generation and s is selection coefficient associated with 
heterozygotes. We used 2x10-8 value for mutation per nucleotide per generation rate estimated by 
Kondrashov21. Importantly, this estimate for cumulative frequency of deleterious alleles does not 
depend on population demographic history.
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The mutation rate for mildly deleterious missense mutations per gene can be estimated as 
follows:
u = [Mutation rate per nucleotide]x[Average gene length]x[Fraction of missenses among all 
substitutions]x[Fraction of mildly deleterious among missenses] {Equation 5a}
u = [2x10-8]x[1500]x[2.23/3.23]x[0.53]=1.1x10-5 {Equation 5b}
Using equation 4, we calculate that for an average gene the combined frequency of alleles 
carrying mildly deleterious missense mutation is approximately 1%.
Taking into account that protein coding sequences comprise approximately 1.5% of the human 
genome, we estimated that approximately 600 missense mutations with selection coefficient 
0.001-0.003 are present in the genome of an average individual. It should be noted that the 
number of mutations with significantly weaker effect on fitness (with associated selection 
coefficients below 10-4) is likely to be significantly higher.
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Discussion
It has been noted that, in some Mendelian diseases, less severe forms of the disease exist, 
associated with milder mutations that do not completely abrogate protein activity1. It was 
suggested that such mildly deleterious missense mutations may serve as a genetic basis of 
complex diseases. The plausibility of this hypothesis depends on how frequent such mildly 
deleterious substitutions are among de novo mutations and how strong the purifying selection 
that acts on them is. The presence of deleterious missense polymorphisms in the human genome 
has been reported in many previous studies43-52. In the present work we performed a quantitative 
analysis, calculating the fraction of mildly deleterious mutations among de novo amino acid 
changes, very rare and very common nsSNPs. Until recently, lack of large resequencing datasets 
that cover dozens of genes and hundreds of chromosomes precluded such analysis, although 
several earlier studies analyzed distribution of selection coefficients for new missense mutations 
in humans and flies using frequency spectrum in smaller samples53,54, dependence of substitution 
rate on effective population size50-52 and comparison of polymorphism and divergence33,53.
We calculated the fraction of mildly deleterious missenses among all de novo substitutions as the 
remaining difference after subtraction of strongly detrimental mutations and effectively neutral 
mutations. We determined that among all de novo amino acid substitutions strongly detrimental 
mutations comprise approximately 20%. The genome-wide value that we obtained is similar to 
the fraction of amino acid replacements which destroy the protein function (25%) obtained by 
Yampolsky et al.33. Our estimate is also in general agreement with the results of Eyre-Walker et 
al.53, who, by fitting a distribution of selection coefficients modeled as a gamma-function to the 
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data on human genetic variation, estimated that approximately 15% of missense substitutions are 
strongly deleterious with selection coefficients above 0.1. Earlier, Fay et al.54 proposed that 54% 
of new missense mutations in humans are strongly deleterious. This estimate referred to the 
fraction of non-synonymous SNPs not observed in the sample of a hundred chromosomes, so this 
estimate is not directly comparable to the estimate presented here. Our value for the fraction of 
effectively neutral amino acid changes (27%) is only very slightly higher than a previous 
estimates50 of 24% and the corresponding KA/KS estimate for human-chimpanzee comparison38 
(23%). The difference is most likely due to the application of the context-based mutation model. 
A smaller previous estimate 12%(ref. 33) possibly resulted from the use of the too distant mouse 
sequence as an outgroup.
On the basis of a very strong difference in Na/Ns ratios for very rare and very common missense 
SNPs, we estimated that the majority of rare missense polymorphisms detected in the human 
population are associated with a surprisingly narrow range of selection coefficients: 0.001-0.003. 
Because of such relatively mild purifying selection acting on them, they can reach a high 
cumulative frequency in the human population, while still maintaining a highly heterogeneous 
spectrum of individual alleles.
An increase in the Na/Ns ratio has been noted previously43, however, the extent of such a 
difference was not always evident because of the low number of chromosome sequenced and 
crude binning by frequency. A strong, “threshold-like” increase in Na/Ns ratio for SNPs with 
frequency below 6% was noted by Wong et al.59 This work, however, has considered this 
observation only as a consequence of massive relaxation of selective constraints in recent human 
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evolution.
We estimated that for an average 500 amino acid protein the cumulative equilibrium frequency 
of alleles carrying deleterious missense SNPs is roughly equal to 1% in the human population. If 
we consider unusually long proteins or entire pathways as mutational targets, their mutation rate, 
and thus, equilibrium frequency of mildly deleterious alleles will be even significantly higher 
than 1%. Some traits, such as susceptibility to complex diseases, can be influenced by dozens or, 
perhaps, even hundreds of genes. The mutational target for such traits will be exceptionally 
large. A large mutational target size leads to a large mutation rate per generation and, as a 
consequence, to a large level of deleterious polymorphism, since at equilibrium it is directly 
proportional to the mutation rate. Even for a simple metabolic pathway that involves several 
multi-subunit enzymes, the fraction of individuals harboring at least one damaging mutation in 
the pathway can easily exceed 10%. This example shows that a combined frequency of rare 
mildly deleterious polymorphisms is high enough to serve as the basis for heritable susceptibility 
even to most common complex diseases such as hypertension or coronary heart disease. This 
suggests the possibility that mutation-selection balance can be a feasible evolutionary 
explanation at least for some common diseases.
Candidate genes association studies
These findings carry implications not only for our understanding of the role of rare 
nonsynonymous SNPs in susceptibility to complex diseases, but also to methods for detecting 
genes that harbor such detrimental genetic variation. Currently, there are two major approaches 
for identification of genes involved in complex diseases: linkage studies60 and association studies 
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of population samples60,61. While the former approach is most effective for identification of 
Mendelian-like rare genetic variants with high penetrance, the latter approach is better suited for 
identification of common variants with relatively low penetrance. None of these approaches, 
however, is able to detect susceptibility loci that harbor numerous, but individually rare, mildly 
deleterious polymorphisms. However, our analysis of mildly deleterious mutations indicates that 
this situation is very plausible and might be true for many genes and common diseases.
In the light of our results, a recently proposed alternative approach looks more promising. This 
approach aims at the detection of enrichment in rare, potentially deleterious missense SNPs in a 
patient group versus a control subject group62,63. By considering the cumulative frequency of 
deleterious mutations rather than their individual frequencies, this method is suitable for 
investigation of common diseases that have very a heterogeneous spectrum of predisposing 
alleles. Such a missense accumulation approach to candidate gene association studies has been 
recently successfully utilized in studies of the MC4R gene64, tyrosine phosphatome in colorectal 
cancers65 and genes involved in lipid metabolism disorders66.
However, two major potential disadvantages of this method have been pointed out62. First is the 
high cost of complete genomic sequencing of candidate genes in a large number of individuals. 
Second is the analytical challenge of selecting potentially deleterious SNPs from a large quantity 
of neutral genetic variation62. The first objection to the method will almost certainly be 
eliminated in the near future by continuing dramatic reduction in sequencing costs67 and 
development of novel sequencing strategies68. The second objection is more fundamental, since 
the inability to distinguish between deleterious and neutral amino acid changes would lead to a 
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very low signal to noise ratio. To study enrichment in deleterious mutations one should be able 
to detect them among neutral genetic variation. The number of deleterious alleles in disease 
phenotypes was previously believed to be low relative to the large number of neutral missense 
SNPs present in both disease and control groups. Our analysis, however, reveals that the majority 
of missense substitutions with detected frequency below 1% are, in fact, deleterious. Thus, if 
only substitutions with detected frequency below 1% are counted, the enrichment in mutations 
number in disease group should be highly pronounced.
Conclusions
A high fraction of mildly deleterious mutations among missense mutations suggests that 
mutation-selection balance is a plausible explanation for the existence of common disease with 
complex inheritance, at least in some cases. Further, it is feasible that some common diseases 
may be caused by a multitude of rare allelic variants. The observation that the majority of human 
rare non-synonymous variants are deleterious, and thus of significance to function and 
phenotype, suggests a strategy for candidate gene association studies. Disease populations are 
expected to have a higher rate of rare amino acid variants than healthy controls in genes involved 
in disease. This difference can be easily detected in a deep re-sequencing study. Obviously, this 
strategy would be highly inefficient if the majority of coding variants at low frequency were 
neutral. Several recent reports demonstrated an excess of rare missense variants in individuals 
with phenotypes associated with disease risk. Our analysis provides an explanation for the 
success of these studies.
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Web resources
The Human Gene Mutation Database (HGMD), http://www.hgmd.cf.ac.uk/ac/index.php
UCSC Sequence and Annotation Downloads, http://hgdownload.cse.ucsc.edu/downloads.html
Consensus CDS (CCDS) project, http://www.ncbi.nlm.nih.gov/CCDS/
SeattleSNPs. NHLBI Program for Genomic Applications, SeattleSNPs, Seattle, WA, 
http://pga.gs.washington.edu
NIEHS SNPs. NIEHS Environmental Genome Project, University of Washington, Seattle, WA, 
http://egp.gs.washington.edu
A database of Japanese Single Nucleotide Polymorphisms (JSNP), http://snp.ims.u-tokyo.ac.jp/
NCBI database of single nucleotide polymorphism (dbSNP), 
http://www.ncbi.nlm.nih.gov/projects/SNP/index.html
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Fig 1 Spectrum of effects of de novo missense mutations
A) Fraction of strongly detrimental mutations among de novo amino acid substitutions. Disease 
causing nonsense mutations in HGMD were used as a standard of “strong detrimentality”; B) 
fraction of strongly detrimental mutations among de novo amino acid substitutions. Disease 
causing splice-site mutations in HGMD were used as a standard of “strong detrimentality”; C) 
Fraction of effectively neutral mutations among de novo amino acid substitutions. Synonymous 
substitutions fixed in the human lineage after divergence from chimpanzee were used as a 
standard of “effective neutrality”.
Fig 2 Fraction of de novo missense mutations represented at different levels of allele 
frequency
Normalized fraction of de novo amino acid substitutions detected in a given dataset was 
calculated from the difference of observed Na/Ns ratio and theoretical Na0/Ns0 ratio expected 
under neutrality. Data for rare polymorphisms are shown in orange, for common polymorphism 
in yellow, and for substitutions fixed in the human lineage after divergence from chimpanzee in 
green. Standard errors are shown by grey error bars.
Fig 3 A) R1/m(s) and RMAF>0.25(s) (see Equation 1a) calculated using equations derived from 
diffusion theory under the assumption of constant population size and an infinite number of sites. 
Expected shift of R1/m(s) curves due to recent population expansion is shown by red arrows. 
Black arrows illustrate estimation of characteristic selection coefficients for mildly deleterious 
class of missense mutations (see Results and Equation 3). B) R1/m(s) and RMAF>0.25(s) calculated by 
direct computer simulation of molecular evolution under the assumption of an infinite number of 
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sites and simple population history – stable population size epoch followed by bottleneck and 
then fast expansion.
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Table 1 Ratios of missense to synonymous SNPs and substitutions.
Dataset Description of 
dataset
Number of 
genes
Theoretical
Na0/Ns0
Singletons
Na/Ns
SNPs with minor 
allele freq. >25%
Na/Ns
Subst. in the 
human lineage
Na/Ns
Singletons
(Na/Ns)/(Na0/Ns0)
SNPs with 
minor allele 
freq. >25%
(Na/Ns)/(Na0/Ns0)
Subst. In the 
human lineage
(Na/Ns)/(Na0/Ns0)
CCDS “genome-wide” 14095 2.232 - - 0.60 - - 0.266+/-0.002
Obesity related 
genes
757 individuals 
sequenced 37 2.204 1.49 - 0.44 0.68+/-0.02 - 0.20+/-0.05
NIEHS-EGP
90-95 
individuals 
sequenced
518 2.255 1.36 0.56 0.50 0.61+/-0.02 0.26+/-0.04 0.22+/-0.01
SeattleSNPs
46-47 
individuals 
sequenced
236 2.203 1.43 0.66 0.66 0.65+/-0.04 0.32+/-0.05 0.30+/-0.02
JSNP 750 individuals genotyped 8786 2.244 1.37* 0.54 0.54 0.61 0.24 0.24
*) SNPs with observed frequency below 1% instead of singletons have been used in analysis of 
JSNP dataset.
44
Table 2 Fraction of deleterious substitutions among rare missense SNPs
Set Number of sequenced 
individuals
Percent of deleterious SNPs 
among missense “singletons”
Resequencing dataset 
of obesity related genes 757 (71+/-8)%
NIEHS-EGP 90-95 (64+/-1)%
SeattleSNPs 46-47 (52+/-6)%
